Vaso Corporation (VASO)
OTC PINK OTC PINK Primary 
Vaso Stock Gains Post Q1 Earnings, Deferred Revenue Grows
VASO's first-quarter 2026 revenues dip after its healthcare IT divestiture, but losses narrow and deferred revenue kept climbing.
Vaso Stock Declines Post Q4 Earnings Despite Revenue Growth
VASO posts steady fourth-quarter 2025 revenues but weaker earnings as higher costs and impairment charges weigh, though core segments and margins show resilience.
Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average – Here’s Why
Vaso Corporation (OTCMKTS:VASO - Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $0.15 and traded as high as $0.17. Vaso shares last traded at $0.17, with a volume of 54,231 shares trading hands. Vaso Stock Performance The
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
VASO reports a third-quarter 2025 profit turnaround with higher revenue, stronger margins and robust cash flow from subscriptions.
Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall
VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.
Vaso Stock Slips Post Q1 Earnings Despite Record Revenue Growth
VASO's first-quarter 2025 revenues hit a record high, but a narrowed net loss and muted stock reaction highlight investor caution despite solid segment growth.
VASO Stock Rises Post Q4 Revenue Growth and Solid Segment Gains
Vaso's fourth-quarter 2024 results reflect record revenue and strong segment growth despite a decline in full-year profit due to higher operating expenses.
VASO Stock Up Despite Q3 Earnings Decline and Rising Costs
Vaso posts third-quarter 2024 revenue growth, but higher costs and a net loss affect profitability.
VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts
Lower revenues from the majority of VASO's segments hurt its second-quarter revenues.
Zacks Initiates Coverage of Vaso With Neutral Recommendation
Discover why Zacks rates Vaso as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore VASO's strategic market presence and financial health amid market challenges.
